Skip to main content

ImmunoChem Therapeutics, LLC

Founded: 2016

Northwestern Inventor:
Martin Watterson
Feinberg School of Medicine
Department of Pharmacology

ImmunoChem Therapeutics, LLC, is a clinical stage start-up developing a new class of brain-specific anti-inflammatory drugs to treat and prevent Alzheimer's disease and other conditions, where brain inflammation is thought to play an important role.